CRCNS: Gamma Rhythms and Cell Assemblies

CRCNS:伽马节律和细胞组装

基本信息

  • 批准号:
    8132866
  • 负责人:
  • 金额:
    $ 32.82万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-01 至 2014-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Gamma frequency oscillations (30-90 Hz) are found in many parts of the nervous system, including the hippocampus, neocortex, entorhinal cortex and amygdala. They are believed to be important for a range of functions, including attention, early sensory processing, short term memory, motor activity. Mental illnesses, notably schizophrenia, are associated with pathologies in this rhythm, and many people are now studying these pathologies for clues to the pathophysiology of the diseases. At a simple level of description, gamma oscillations are thought to come about as interactions of parvalbumin positive (PV+) fast-spiking (FS) interneurons and pyramidal cells. However, it is known that other cell types, especially interneurons, participate in gamma rhythms and/or may modulate power and coherence of those rhythms. To understand the functional importance of these rhythms, it is necessary to better understand mechanisms that create and modulate them. Here we propose to use, for the first time, the combination of mathematical modeling with application of a set of emerging techniques involving molecular biology, optics, and electrophysiology to study the cell-type specific and circuitry properties of networks that produce gamma oscillations in the cortex. We will use in vitro models of the primary auditory cortex, with gamma oscillations induced using the glutamatergic agonist kainate or the cholinergic agonist carbachol. Specific classes of cells will be activated or suppressed by brief or longer periods of light. The work will focus on pyramidal cells, PV+ cells, cholecystokinin-expressing (CCK+) cells and somatostatin-containing (SOM+) interneurons. Minimal models will be constructed of these cells types and networks containing all of them. The model networks will be used to understand how the CCK+ and SOM+ interneurons interact with the PV+ cells to alter the gamma rhythms, in connection with experimental manipulations of the activity of different cell types. The experiments and models will also be used to understand how the CCK+ and SOM+ cells may affect the creation of cells assemblies. Broader Impacts: This work is part of a broader set of research by these labs on the importance of dynamics in cognitive function. The investigator is head of the Cognitive Rhythms Collaborative in the Boston area, a group of about 20 senior scientists, whose aim is to create and support new collaborations, including those making use of basic science and modeling in the study of disease, including Epilepsy, Parkinson's Disease, Autism and Schizophrenia. The work done in this project will provide new science that will interact with the work of many others in that group. The experimental work provides, for the first time, a combination of molecular biology, optics, and electrophysiology to study the cell-type specific and circuitry properties of networks; these techniques, pioneered by a member of this group, can then be used in many other contexts, beyond this group. The techniques and results will help provide information about the pathophysiology of mental illnesses; this has the potential of controlling such diseases by correcting the "oscillapathy" (defects in brain dynamics) associated with the symptoms. Finally, the specific project will also help train two graduate students and a postdoctoral fellow.
描述(由申请人提供):伽马频率振荡(30-90 Hz)存在于神经系统的许多部分,包括海马体、新皮质、内嗅皮质和杏仁核。它们被认为对一系列功能很重要,包括注意力、早期感觉处理、短期记忆、运动活动。精神疾病,特别是精神分裂症,与这种节律的病理有关,许多人现在正在研究这些病理,以寻找疾病的病理生理学线索。在一个简单的描述水平上,γ振荡被认为是小白蛋白阳性(PV+)快速尖峰(FS)中间神经元和锥体细胞的相互作用。然而,已知其他细胞类型,特别是中间神经元,参与γ节律和/或可以调节这些节律的功率和相干性。为了理解这些节律的功能重要性,有必要更好地理解创建和调节它们的机制。在这里,我们建议使用,第一次,数学建模与应用程序的一组新兴技术,涉及分子生物学,光学和电生理学研究细胞类型的具体和电路特性的网络,产生伽马振荡在皮层。我们将使用初级听觉皮质的体外模型,使用谷氨酸能激动剂红藻氨酸或胆碱能激动剂卡巴胆碱诱导γ振荡。特定类别的细胞将被短暂或较长时间的光照激活或抑制。这项工作将集中在锥体细胞,PV+细胞,胆囊收缩素表达(CCK+)细胞和含生长抑素(SOM+)的中间神经元。将构建这些细胞类型和包含所有这些细胞的网络的最小模型。模型网络将用于了解CCK+和SOM+中间神经元如何与PV+细胞相互作用以改变伽马节律,并结合不同细胞类型的活动的实验操作。实验和模型也将用于了解CCK+和SOM+细胞如何影响细胞组装体的产生。更广泛的影响:这项工作是这些实验室关于认知功能中动态重要性的更广泛研究的一部分。该研究人员是波士顿地区认知节律合作组织的负责人,该组织由大约20名资深科学家组成,其目的是创建和支持新的合作,包括在疾病研究中利用基础科学和建模的合作,包括癫痫,帕金森病,自闭症和精神分裂症。在这个项目中所做的工作将提供新的科学,将与该小组中许多其他人的工作相互作用。实验工作首次提供了分子生物学,光学和电生理学的组合,以研究网络的细胞类型特异性和电路特性;这些技术由该组成员开创,然后可以在该组之外的许多其他环境中使用。这些技术和结果将有助于提供有关精神疾病病理生理学的信息;这有可能通过纠正与症状相关的“情感淡漠”(大脑动力学缺陷)来控制此类疾病。最后,具体项目还将帮助培养两名研究生和一名博士后。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(4)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NANCY KOPELL其他文献

NANCY KOPELL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NANCY KOPELL', 18)}}的其他基金

Computational Core
计算核心
  • 批准号:
    10633811
  • 财政年份:
    2023
  • 资助金额:
    $ 32.82万
  • 项目类别:
Project 4: Mathematical Modeling Studies of Anesthetic Action
项目4:麻醉作用的数学模型研究
  • 批准号:
    9209580
  • 财政年份:
    2017
  • 资助金额:
    $ 32.82万
  • 项目类别:
Project 5: Computational
项目 5:计算
  • 批准号:
    10175037
  • 财政年份:
    2017
  • 资助金额:
    $ 32.82万
  • 项目类别:
Project 4: Mathematical Modeling Studies of Anesthetic Action
项目4:麻醉作用的数学模型研究
  • 批准号:
    10093080
  • 财政年份:
    2017
  • 资助金额:
    $ 32.82万
  • 项目类别:
CRCNS: Gamma Rhythms and Cell Assemblies
CRCNS:伽马节律和细胞组装
  • 批准号:
    8133160
  • 财政年份:
    2009
  • 资助金额:
    $ 32.82万
  • 项目类别:
CRCNS: Gamma Rhythms and Cell Assemblies
CRCNS:伽马节律和细胞组装
  • 批准号:
    8326121
  • 财政年份:
    2009
  • 资助金额:
    $ 32.82万
  • 项目类别:
CRCNS: Gamma Rhythms and Cell Assemblies
CRCNS:伽马节律和细胞组装
  • 批准号:
    8535286
  • 财政年份:
    2009
  • 资助金额:
    $ 32.82万
  • 项目类别:
CRCNS: Gamma Rhythms and Cell Assemblies
CRCNS:伽马节律和细胞组装
  • 批准号:
    7777645
  • 财政年份:
    2009
  • 资助金额:
    $ 32.82万
  • 项目类别:
High-Frequency Rhythms of the Neocortex: Mechanisms and Interactions
新皮质的高频节律:机制和相互作用
  • 批准号:
    7502480
  • 财政年份:
    2009
  • 资助金额:
    $ 32.82万
  • 项目类别:
Rhythms of the Nervous System
神经系统的节律
  • 批准号:
    6941594
  • 财政年份:
    2002
  • 资助金额:
    $ 32.82万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 32.82万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 32.82万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 32.82万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 32.82万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 32.82万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 32.82万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 32.82万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 32.82万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 32.82万
  • 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
  • 批准号:
    23K05057
  • 财政年份:
    2023
  • 资助金额:
    $ 32.82万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了